The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Hibbs Kathy L since year 2005.
The trader's CIK number is 1267487.
At the time of this reporting, Hibbs Kathy L is the VP, General Counsel of Genomic Health Inc .
(stock ticker symbol GHDX).
See this page for all insider trading activities at Genomic Health Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-02-18||GHDX||Genomic Health Inc||Sale||1,312||27.88||36,583|
|2013-05-22||GHDX||Genomic Health Inc||Sale||1,000||37.48||37,480|
|2013-05-22||GHDX||Genomic Health Inc||Option Ex||1,000||21.07||21,070|
|2013-05-13||GHDX||Genomic Health Inc||Option Ex||1,250||21.07||26,337|
|2013-05-13||GHDX||Genomic Health Inc||Sale||1,250||34.42||43,031|
|2013-02-20||GHDX||Genomic Health Inc||Sale||2,716||28.13||76,398|
|2012-10-11||GHDX||Genomic Health Inc||Sale||1,250||33.78||42,223|
|2012-10-11||GHDX||Genomic Health Inc||Option Ex||1,250||21.07||26,337|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hibbs Kathy L (VP, General Counsel of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.